Requiring a pharmacist, or the pharmacist's designee who is under certain supervision, to inform a certain consumer of the availability of a therapeutically equivalent brand name drug that is the lowest cost alternative to the originally prescribed drug or device and the cost difference between the therapeutically equivalent drug or device and the prescribed drug; altering the cost difference of which a pharmacist is required to inform a retail consumer; requiring a certain determination to be made based on a certain drug benefit; etc.
Bill File Type: Regular
Effective Date(s): October 1, 2021
HistoryToggle History Dropdown
File CodeToggle Filecode Dropdown
SubjectsToggle Subjects Dropdown
StatutesToggle Statutes Dropdown
Last Updated: 2/18/2021 12:48 PM